Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 404

1.

Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.

Xiao GQ, Song JL, Shen S, Yang JY, Yan LN.

World J Gastroenterol. 2014 Aug 21;20(31):10953-9. doi: 10.3748/wjg.v20.i31.10953.

PMID:
25152599
[PubMed - in process]
2.

Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.

Xu XS, Wan Y, Song SD, Chen W, Miao RC, Zhou YY, Zhang LQ, Qu K, Liu SN, Zhang YL, Dong YF, Liu C.

World J Gastroenterol. 2014 Aug 21;20(31):10944-52. doi: 10.3748/wjg.v20.i31.10944.

PMID:
25152598
[PubMed - in process]
3.

Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation.

Teng F, Wang GH, Tao YF, Guo WY, Wang ZX, Ding GS, Shi XM, Fu ZR.

World J Gastroenterol. 2014 Aug 21;20(31):10900-7. doi: 10.3748/wjg.v20.i31.10900.

PMID:
25152592
[PubMed - in process]
4.

Prognosis Evaluation in Patients with Hepatocellular Carcinoma after Hepatectomy: Comparison of BCLC, TNM and Hangzhou Criteria Staging Systems.

Liu C, Duan LG, Lu WS, Yan LN, Xiao GQ, Jiang L, Yang J, Yang JY.

PLoS One. 2014 Aug 18;9(8):e103228. doi: 10.1371/journal.pone.0103228. eCollection 2014.

PMID:
25133493
[PubMed - in process]
Free PMC Article
5.

Current management of hepatocellular carcinoma.

Tabrizian P, Roayaie S, Schwartz ME.

World J Gastroenterol. 2014 Aug 14;20(30):10223-10237. Review.

PMID:
25132740
[PubMed - as supplied by publisher]
Free PMC Article
6.

Hepatic radioembolization as a bridge to liver surgery.

Braat AJ, Huijbregts JE, Molenaar IQ, Borel Rinkes IH, van den Bosch MA, Lam MG.

Front Oncol. 2014 Jul 30;4:199. doi: 10.3389/fonc.2014.00199. eCollection 2014. Review.

PMID:
25126539
[PubMed]
Free PMC Article
7.

Side effects of yttrium-90 radioembolization.

Riaz A, Awais R, Salem R.

Front Oncol. 2014 Jul 29;4:198. doi: 10.3389/fonc.2014.00198. eCollection 2014. Review.

PMID:
25120955
[PubMed]
Free PMC Article
8.

Cutaneous Metastases from Primary Hepatobiliary Tumors as the First Sign of Tumor Recurrence following Liver Transplantation.

Hauch AT, Buell JF, McGowan M, Bhatia P, Lewin E, Killackey M, Shores NJ, Balart LA, Moehlen M, Saggi B, Paramesh AS.

Case Rep Transplant. 2014;2014:838949. doi: 10.1155/2014/838949. Epub 2014 Jul 10.

PMID:
25120936
[PubMed]
Free PMC Article
9.

A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma.

Park EK, Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Kim JW, Cho CK.

Ann Surg Treat Res. 2014 Aug;87(2):72-80. doi: 10.4174/astr.2014.87.2.72. Epub 2014 Jul 29.

PMID:
25114886
[PubMed]
Free PMC Article
10.

(18)F-Fluorodeoxyglucose positron-emission tomography could have a prognostic role in patients with advanced hepatocellular carcinoma.

Simoneau E, Hassanain M, Madkhali A, Salman A, Nudo CG, Chaudhury P, Metrakos P.

Curr Oncol. 2014 Aug;21(4):e551-6. doi: 10.3747/co.21.1959.

PMID:
25089106
[PubMed]
Free PMC Article
11.

Wavelet-based algorithm to the evaluation of contrasted hepatocellular carcinoma in CT-images after transarterial chemoembolization.

Alvarez M, de Pina DR, Romeiro FG, Duarte SB, Miranda JR.

Radiat Oncol. 2014 Jul 26;9:166. doi: 10.1186/1748-717X-9-166.

PMID:
25064234
[PubMed - in process]
Free PMC Article
12.

Nucleot(s)ide Analogues for Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Treatment: A Systematic Review and Meta-Analysis.

Sun P, Dong X, Cheng X, Hu Q, Zheng Q.

PLoS One. 2014 Jul 24;9(7):e102761. doi: 10.1371/journal.pone.0102761. eCollection 2014.

PMID:
25058587
[PubMed - in process]
Free PMC Article
13.
14.

Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia.

Kim DS, Yu YD, Jung SW, Yang KS, Seo YS, Um SH, Suh SO.

Ann Surg Treat Res. 2014 Jul;87(1):22-7. doi: 10.4174/astr.2014.87.1.22. Epub 2014 Jun 24.

PMID:
25025023
[PubMed]
Free PMC Article
15.

Shall we take a second thought before applying radiofrequency ablation for resectable HCC ≤2 cm?

Liao M, Huang J, Wu H, Zeng Y.

Hepatobiliary Surg Nutr. 2014 Jun;3(3):109-11. doi: 10.3978/j.issn.2304-3881.2014.06.01.

PMID:
25019070
[PubMed]
Free PMC Article
16.
17.

Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

Zhang S, Liang X, Zheng X, Huang H, Chen X, Wu K, Wang B, Ma S.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2079-90. eCollection 2014.

PMID:
24966916
[PubMed - in process]
Free PMC Article
18.

Living donor liver transplantation for patients with hepatocellular carcinoma.

Akamatsu N, Sugawara Y, Kokudo N.

Liver Cancer. 2014 May;3(2):108-18. doi: 10.1159/000343866. Review.

PMID:
24945001
[PubMed]
Free PMC Article
19.

Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation.

Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK.

World J Gastroenterol. 2014 Jun 7;20(21):6594-601. doi: 10.3748/wjg.v20.i21.6594.

PMID:
24914382
[PubMed - in process]
Free PMC Article
20.

Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy.

Park TY, Na YC, Lee WH, Kim JH, Chang WS, Jung HH, Chang JH, Chang JW, Park YG.

Brain Tumor Res Treat. 2013 Oct;1(2):78-84. doi: 10.14791/btrt.2013.1.2.78. Epub 2013 Oct 31.

PMID:
24904896
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk